E-therapeutics (ETX)

Company name:E-therapeutics Plc
EPIC:ETXTrading Currency:GBX
Market Sector:ASM8ISIN:GB00B2823H99
Market Segment:AMSMShare Type:DE
WWW Address:http://www.etherapeutics.co.uk/Description:ORD 0.1P
 Price Price Change [%] Bid Offer Open High Low Volume
 22.80 images.advfn.com/imagesnew/2/gb/up 1.75 [8.31] 22.60 23.00 21.60 23.00 21.50 1,193,077
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 117.32 514.55 -0.01 -0.99 - - - 33.00 - 11.30

E-therapeutics Key Figures

(at previous day's close)
Market Cap.117.32m
Shares In Issue514.55m
Prev. Close21.05
PE Ratio- 
Dividend Yield-%
EPS - basic-0.99p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.65p
Return On Equity (ROE)-26.53%
Operating Margin-1,409.46%
PEG Factor- 
EPS Growth Rate-13.79%
Dividends PS Growth Rate-%
Net Debt-12.60m
Gross Gearing2.98%
Quick Assets14.15m
Net Working Capital13.72m
Intangibles / Fixed Assets50.62%
Turnover PS0.06p
Pre-Tax Profit PS-0.87p
Retained Profit PS-0.72p
Cash PS2.53p
Net Cash PS2.45p
Net Tangible Asset Value PS *2.68p
Net Asset Value PS2.70p
Spread0.40 (1.74%) 

E-therapeutics Balance Sheet


Share Price Performance

Sample Period HighLow
1 week23.0018.30
4 weeks24.4018.30
12 weeks33.0018.30
1 year33.0011.30

Share Price Chart (5 years)

E-therapeutics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week20.002.8014.0018.300.9920.85
4 weeks24.30-1.50-6.1718.300.4721.08
12 weeks31.00-8.20-26.4518.300.5525.23
26 weeks19.503.3016.9218.200.7324.00
1 year11.5511.2597.4011.300.8918.84
3 years7.1015.70221.131.431.827.53
5 years12.5010.3082.401.431.407.72

E-therapeutics Key Management Ratios

E-therapeutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 12.29 
Tobin's Q Ratio (excl. intangibles)12.41 
Dividend Yield-%
Market-to-Book Ratio8.45 
Price-to-Pre-Tax Profit PS-26.26 
Price-to-Retained Profit PS-31.85 
Price-to-Cash Flow PS-34.94 
Price-to-Sales PS370.09 
Price-to-Net Tangible Asset Value PS8.50 
Price-to-Cash PS9.01 
Net Working Capital PS2.67 
Price Pct to Working Capital PS8.55%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

E-therapeutics Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-88.04%
Net Gearing (excl. Intangibles)-88.55%
Gross Gearing2.98%
Gross Gearing (excl. Intangibles)3.00%
Gearing Under 1 Year2.98%
Gearing Under 1 Year (excl. Intgbl)3.00%
(Liquidity Ratios)
Net Working Capital to Total Assets95.88%
Current Ratio33.14 
Quick Ratio (Acid Test)33.14 
Liquidity Ratio30.51 
Cash & Equiv/Current Assets92.07%
(Solvency Ratios)
Enterprise Value104.29m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.00 
Total Debt/Sales1.35 
Total Debt/Pre-Tax Profit-0.10 
Total Debt0.43m
Total Debt/Net Current Assets0.03%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-12.74%
5 yr Compound Earnings Growth-27.40%
10 yr Compound Earnings Growth-8.74%
Earn drops > 5% in 10yrs6 
Beta (60-Mnth)Beta (36-Mnth)

E-therapeutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-32.18%
Return On Assets (ROA)-38.58%
Net Profit Margin-1,162.15%
Assets Turnover0.03 
Return On Equity (ROE)-26.53%
Return On Investment (ROI)-40.02%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-1,162.15%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.03 
Fixed Assets Turnover1.74 
Current Assets Turnover0.03 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales30.12 
Debt Collection Period1,073.12Days

E-therapeutics Dividends

Sorry No Data Available

E-therapeutics Fundamentals

 31 Jan 2018 (GBP)31 Jan 2019 (GBP)31 Jan 2020 (GBP)31 Jan 2021 (GBP)
pre tax profit-6.72--5.09--2.87--4.47-m
attributable profit-5.36--4.00--2.35--3.68-m
retained profit-5.36--4.00--2.35--3.68-m
eps - basic (p)-2.00 -1.49 -0.87 -0.99 
eps - diluted (p)-2.00 -1.49 -0.87 -0.99 
dividends per share- - - - 

E-therapeutics Balance Sheet

 31 Jan 2018 (GBP)31 Jan 2019 (GBP)31 Jan 2020 (GBP)31 Jan 2021 (GBP)
 31 Jan 2018 (GBP)31 Jan 2019 (GBP)31 Jan 2020 (GBP)31 Jan 2021 (GBP)
fixed assets fixed assets0.070.60%0.040.56%0.091.94%0.080.56%m
intangibles intangibles0.141.15%0.121.58%0.112.30%0.080.57%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other2.5021.25%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors1.9616.66%1.4419.23%0.7415.50%1.127.84%m
cash & securities cash & securities7.1060.34%5.9078.63%3.8480.25%13.0391.03%m
creditors - short creditors - short1.028.71%0.719.42%0.265.45%0.432.98%m
creditors - long creditors - long--%--%0.020.48%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves10.7491.29%6.8090.58%4.5094.07%13.8897.02%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

E-therapeutics Cash Flow Statement

31 Jan 2018 (GBP)31 Jan 2019 (GBP)31 Jan 2020 (GBP)31 Jan 2021 (GBP)
Operating CF-4.41-3.70-2.03-3.36m
Pre-Financing CF2.61-1.20-2.03-3.41m
Retained CF2.62-1.19-2.069.19m

E-therapeutics Brokers

Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210725 23:29:09